Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • A letter of approval from the corresponding research and/or ethics committee must be submitted. All original articles must have been reviewed and approved by a duly constituted research and/or ethics committee, following the guidelines established for such bodies.
  • A letter signed by the corresponding author or by all authors must be submitted, certifying that the article was checked using anti-plagiarism software, together with the corresponding evidence, or alternatively, the similarity report itself should be attached, with a result lower than 20%.
  • A copyright transfer form signed by all authors must be submitted. The form can be found at the following link:
    https://uninorte-my.sharepoint.com/:w:/g/personal/saluduninorte_uninorte_edu_co/EWa2jrjQnhpcLQxyVspOqrgBHP-nrJnXfWe0o-27_0uGkw?e=orkjUf
  • The manuscript (Microsoft Word document) must be submitted with the information arranged in the following order:

    1. Title (in Spanish and English).
    2. Abstract and keywords (in Spanish and English).
    3. Main text (structured according to the article type).
    4. Tables and figures inserted in their corresponding place, with title and source. If produced by the authors, this must be indicated.
    5. References.
  • In a separate Microsoft Word document, the following information for each author must be provided:

    1. Full name of the authors.
    2. Academic degrees and the institution that awarded them.
    3. Institutional affiliation.
    4. Email addresses.
    5. Mobile phone number.
    6. ORCID.
    7. CvLAC.
    8. Funding: If the work has received funding, the source and project number from the funding institution must be included.
  • Three (3) qualified professionals must be proposed to review the manuscript. These must not belong to the same university or organisation as the authors. The following information must be included for each suggested reviewer:

    1. Full name.
    2. Institutional affiliation.
    3. Email address.
    4. ORCID.
    5. Google Scholar profile.
    6. Most recent publications in indexed journals.

Author Guidelines

CROSS-CUTTING REQUIREMENTS FOR ALL CATEGORIES

Language and Format

  • Manuscripts in Spanish or English. Title, abstract, and keywords in both languages.

  • Reference style: Vancouver (numeric). Include DOI.

  • Units: SI.

  • Abbreviations: Define at first use; avoid in title/abstract.

Ethics, Integrity and Transparency

  • Declare ethics committee approval and consent.

  • Conflicts of interest: ICMJE form.

  • Funding: Source and role.

  • Data/materials/code availability: Mandatory declaration; deposition in OSF/Zenodo (with DOI) is recommended.

  • Authorship/Contributions: Use CRediT; no restriction on number of authors.

  • Originality: Plagiarism check; no simultaneous submission.

  • Registration: Clinical trials (ClinicalTrials.gov or other); Reviews (PROSPERO/OSF).

File Presentation

  • Main manuscript: .docx, numbered lines and double spacing, no names included. Attach another Word file with names included.

  • Figures: TIFF/PNG (≥300 dpi) or EPS/SVG; no dark backgrounds.

  • Tables: Editable (not images); title and notes below the table.

  • Supplementary material: Accepted (protocols, checklists, datasets, code).

Editorial Assessment Criteria (Summary Rubric)

  • Relevance and originality.

  • Methodological rigour.

  • Analytical soundness.

  • Ethics and integrity.

  • Clarity and structure.

  • Quality and usefulness of tables/figures.

Common Reasons for Immediate Rejection

  • Absence of required ethical approval/consent.

  • Lack of mandatory trial/review registration.

  • Methodology inconsistent with the research question.

  • Only p-values without effect size and CI.

  • Plagiarism or duplicate submission.

PRESENTATION AND STRUCTURE OF MANUSCRIPTS

1. General Manuscript Format

  • Paper: Letter (21.6 × 27.9 cm).

  • Software: Microsoft Word (.docx).

  • Font: Times New Roman or Arial, size 12, double line spacing.

  • Margins: 2.5 cm on all sides.

  • Justified text, consecutive pagination.

  • Written in the active voice and impersonal style.

  • Following peer review, the manuscript will undergo technical editing. The Editorial Committee may condense, suppress, or add elements. The edited version will be sent to the corresponding author for approval. Lack of response or satisfactory clarification may be grounds for definitive rejection.

2. Manuscript Order (each component on a separate page)

  1. Title page (cover sheet).

  2. Abstract and keywords (in Spanish and English).

  3. Main text (structure according to type).

  4. Bibliographic references.

  5. Tables.

  6. Figures.

  7. Supplementary material (if applicable).

3. Title Page

Must include:

  • Article title: Clear, informative, in Spanish and English; no abbreviations.

  • Authors: Name, two surnames, academic degree, current institutional affiliation, email address, mandatory ORCID, link to CvLAC (Colombian authors).

  • Corresponding author: Full name, postal address, telephone number, email address.

  • Institution where the work was carried out.

  • Funding: Source(s), project number, and role of the funder.

  • Conflicts of interest: According to ICMJE format.

  • Authorship contributions: Following the CRediT taxonomy.

4. Abstract and Keywords

  • Length: Maximum 250 words (150 for special articles/brief communications).

  • Languages: Spanish and English.

  • Structure:

    • Original articles: Objective, Methods, Results, Conclusions.

    • Case reports/clinical notes: Brief introduction, Case presentation, Conclusions.

  • References and abbreviations are not permitted in the abstract.

  • Keywords (3–10): From DeCS and MeSH.

5. Main Text

  • Original articles: Introduction, Methods, Results, Discussion, Conclusion, Acknowledgements, Funding, Conflicts of interest, declaration of Artificial Intelligence use.

  • Case reports/clinical notes: Introduction, Case presentation, Discussion.

  • Systematic reviews: Introduction, Methods, Results, Discussion, Conclusion.

  • Abbreviations: Minimal use, define the first time. Avoid in title, abstract, and keywords.

  • Decimal numbers: Comma in Spanish (2,5), full stop in English (2.5).

  • Units of measurement: International System (SI); may be accompanied by traditional units.

  • Medicines: Generic name.

  • Instruments/equipment: Brand, model, and manufacturer in parentheses.

6. References

  • Style: Vancouver, numbered in order of appearance, with Arabic numerals in parentheses.

  • Cite journals with the official Index Medicus abbreviation.

  • Include the DOI when it exists.

  • Avoid references to personal communications, unpublished data, or manuscripts in preparation.

  • Include relevant literature from Latin America is recommended.

  • Examples:

    • Journal article: Rodriguez-Velásquez J, Prieto-Rodríguez S, Flórez-Cárdenas M, et al. Sistemas dinámicos cardiacos en neonatos normales: Ley caótica cardiaca neonatal. Salud Uninorte. 2014;30(3):361-370. doi:10.14482/sun.30.3.5757

    • Book chapter: Weinstein L, Swartz MN. Patogenic properties of invading microorganisms. In: Sodeman WA Jr, Sodeman WA, editors. Pathologic Physiology: Mechanisms of Disease. 3rd ed. Philadelphia: WB Saunders; 1974. p. 457-72.

    • Online article: Romero-Pérez I, Monterrosa-Castro A, Paternina-Caicedo A. El sobrepeso y la obesidad se asocian a mayor prevalencia de síntomas menopáusicos y deterioro severo de la calidad de vida. Salud Uninorte [Internet]. 2014 [cited 2015 Oct 30];30(2):180-191. Available from: http://rcientificas.uninorte.edu.co/index.php/salud/article/view/5077/6998

7. Tables

  • Numbered with Arabic numerals, in order of appearance.

  • Presented on separate pages, double-spaced.

  • Brief and clear title at the top.

  • Abbreviations explained in a footnote.

  • Do not duplicate information in text and figures.

  • Send an editable file (Excel or Word).

8. Figures

  • Numbered consecutively with Arabic numerals.

  • Files: TIFF/PNG (300 dpi minimum) for photographs; EPS/SVG for illustrations or graphs.

  • Graphs with identified axes, scales, units, and symbols.

  • Microphotographs with scale bar and magnification.

  • Patient figures: Anonymisation guaranteed; if identifiable, written informed consent is required.

  • Include source or credit in the figure legend, with citation.

9. Supplementary Material

Authors may attach online:

  • Protocols, questionnaires, checklists.

  • Anonymised databases.

  • Statistical code.

  • Videos, audio, or additional images.

ETHICAL RESPONSIBILITIES

Permissions for Reproduction

Authors are responsible for obtaining the necessary permissions to reproduce material previously published (text, tables, or figures) in Salud Uninorte.

Permissions must be requested from the original author and the publisher.

Authorship

The list of authors must include only those who have made a substantial intellectual contribution.

Each author must provide a detailed description of their contribution, according to ICMJE.

Compliance with Ethical Standards

Manuscripts must explicitly indicate compliance with the ethical standards of the institutional or regional committee and the principles of the Declaration of Helsinki (2008).

  • Clinical trials: Must adhere to CONSORT guidelines.

  • Experiments with animals: Compliance with applicable regulations (e.g., ARRIVE guidelines).

Informed Consent

  • Declare in the Methods section that procedures with patients or controls were performed after obtaining informed consent and/or assent.

  • The study must have been reviewed and approved by an ethics committee.

  • Authors must provide a copy of the approval letter.

ARTICLE SUBMISSION

Articles submitted to Salud Uninorte must be accompanied by a copyright transfer letter, signed by all authors, declaring:

  • Exclusivity for Salud Uninorte; not submitted to another publication nor previously published (except conference abstracts).

  • Authors' responsibility for the content and research.

  • Active participation in design, analysis, interpretation, writing, and critical revision; approval of the final text.

  • No agreements with commercial product companies, or explicit declaration of the relationship.

  • Transparent declaration of other conflicts of interest.

  • Consent from persons mentioned in the acknowledgements.

Submission Platform (OJS)

  1. Register at: http://rcientificas.uninorte.edu.co/index.php/salud/user/register

  2. Complete the registration form.

  3. Select the Author checkbox to enable submission.

  4. Once registered, you will receive a confirmation email. To submit a manuscript:

    • Select [New Submission] in the Author profile.

    • Complete the five steps:

      1. Checklist.

      2. Upload of the main file.

      3. Entering metadata.

      4. Uploading supplementary documents (tables, appendices, figures, etc.).

      5. Confirmation of submission.

  • The system will notify the editor. Please verify that you have completed all steps if you do not receive confirmation.

  • Technical recommendation: Tables and graphs in separate Excel files. Images and figures in JPG with a minimum of 300 dpi.

Editorial Review and Peer Evaluation

  • The Editorial Committee will acknowledge receipt and perform a preliminary filter.

  • Articles will be evaluated by at least two external reviewers under a double-blind system.

  • Authors should suggest three (3) potential reviewers.

  • Reviewers may recommend acceptance, modification, or rejection.

  • In case of modifications, the corresponding author will have one (1) week to submit the corrected version.

  • If the manuscript is accepted, authors must sign and send the copyright transfer within three (3) days.

  • During proof correction, the lead author will receive the files and must return them within two (2) days.

Open Access Policy

Salud Uninorte is an open access journal. Articles are distributed under a Creative Commons CC BY-NC 4.0 licence, permitting use, distribution, and reproduction for non-commercial purposes, with proper citation and respect for copyright.

For more information, please consult:
Guevara M, Hincapié J, Jackman J, Herrera O, Caballero C. Revisión por pares: ¿Qué es y para qué sirve? Salud Uninorte. 2008;24(2):258-72. Available from: http://rcientificas.uninorte.edu.co/index.php/salud/article/view/1847/1204.

LETTERS TO THE EDITOR

  • Scope: Critical comments on articles published in the journal, well-founded hypotheses, or preliminary results with a novel contribution.

  • Length: Up to 500 words.

  • References: Up to 10.

  • Tables/figures: Up to 2.

  • No abstract or formal sections.

  • Specific requirements:

    • If commenting on an article from the journal, cite it and add its DOI in the first reference.

    • Send within 60 days of the commented article's publication (recommended).

    • Argumentation must be evidence-based.

    • Unpublished data only if minimal, with clear methods and ethical approvals.

    • The Editorial Committee may invite a reply from the authors of the commented article.

ORIGINAL ARTICLE

  • Scope: Unpublished research (quantitative, qualitative, or mixed-methods) in health, including clinical trials, cohort studies, case-control studies, cross-sectional studies, correlational studies, diagnostic accuracy studies, prognostic studies, health systems interventions, and qualitative/mixed-methods studies.

  • Length: Up to 2,500 words (excluding abstract, references, tables, or figures).

    • Introduction: maximum 500 words.

    • References: up to 50.

    • Tables/figures: maximum 8.

  • Mandatory Structure: IMRAD (Introduction, Methods, Results, and Discussion). [See note above on IMRAD]

  • Structure Components:

    • Title: Concise, informative, and without acronyms.

    • Structured abstract (250 words): Introduction/Objective, Materials and methods, Results, Conclusions.

    • Keywords: 3-6, in Spanish and English, taken from MeSH/DeCS.

    • Introduction: Knowledge gap, background, context, research question, and main objective.

    • Methods:

      • Study design.

      • Reporting methodology according to design: CONSORT (clinical trials), STROBE (observational), STARD (diagnostic accuracy), TRIPOD (predictive models), COREQ/SRQR (qualitative).

      • Setting/sample, inclusion/exclusion criteria.

      • Variables (operationalisation).

      • Procedures.

      • Sample size calculation.

      • Management of losses and biases.

      • Psychometric properties of instruments.

      • Software(s) and version(s) used.

      • Applied statistical models, verified assumptions, handling of missing data, and adjustments for multiplicity.

      • Protocol registration (e.g., ClinicalTrials.gov) where applicable.

      • Ethics committee approval.

    • Results: Clear, coherent, and aligned with the objectives.

      • For specific guidelines on reporting results for each study type (e.g., CONSORT flow, STROBE items), please refer to the respective EQUATOR Network guidelines.

    • Discussion: Synthesis of main findings, comparison with literature, biological/social plausibility, limitations, clinical/policy implications, future directions.

    • Conclusions: Clear, proportionate to the evidence, and coherent with the objectives.

    • Final sections: Acknowledgements, Funding (source and role), Conflicts of interest, Data and code availability (in an open repository), Ethical approval, Informed consent/assent.

  • EQUATOR guidelines according to design: CONSORT, STROBE, STARD, TRIPOD, SQUIRE, CHEERS, COREQ/SRQR.

    • Attach the corresponding checklist as a supplementary file.

  • Minimum statistics requirements:

    • Report estimators and 95% CI, not just p-values.

    • Specify models, verification of assumptions, variable selection strategy, and handling of confounders.

    • Declare method for handling missing data.

    • Correction for multiple comparisons.

    • Share code (R, Python, Stata do-file) and version of packages.

  • Figures and Tables

    • Formats: TIFF/PNG 300 dpi (photographs) or EPS/SVG (vector graphics).

    • Avoid tiny text; use standardised units.

    • Do not duplicate data from tables in the text.

SYSTEMATIC REVIEWS (WITHOUT META-ANALYSIS)

  • Scope: Synthesis of evidence (effectiveness, diagnosis, prognosis, prevalence, qualitative or mixed-methods).

  • Length: Up to 4,000 words (excluding abstract, references, tables/figures).

  • References: ≥ 50.

  • Tables/figures: Up to 12.

  • Structure:

    • Title: Indicate "Systematic review" and if it includes a meta-analysis.

    • Registration: PROSPERO (or OSF) registration mandatory; include ID.

    • Structured abstract (250 words): Background, Objective, Methods, Results, Conclusions, Registration.

    • Keywords: MeSH/DeCS.

    • Introduction: Justification and question (PICO/PEO/SPIDER).

    • Methods (PRISMA 2020): Reproducible search strategy (≥3 databases + grey literature, no language limits by default), management of duplicates, double-reviewer screening, PRISMA flowchart, inclusion/exclusion criteria, duplicate data extraction, risk of bias (Cochrane RoB 2, ROBINS-I, QUADAS-2, Newcastle-Ottawa/STROBE-based), GRADE for certainty of evidence. Synthesis: meta-analysis (random effects by default), heterogeneity (I², τ²), publication bias, pre-specified meta-regression/subgroups, sensitivity analysis.

    • Results: Characteristics of studies (table), risks of bias, forest plots with effects and 95% CI.

    • Discussion: Interpretation via GRADE, limitations of the evidence and of the review, implications.

    • Conclusions.

  • Supplementary material: Complete search strategy, extraction forms, GRADE tables, PRISMA checklists.

  • Notes: For qualitative reviews, use ENTREQ; for scoping reviews, PRISMA-ScR. Deposit extraction dataset and code in an open repository.

SYSTEMATIC REVIEWS AND META-ANALYSES

  • Scope: Synthesis of evidence (effectiveness, diagnosis, prognosis, prevalence, qualitative or mixed-methods).

  • Length: Up to 4,000 words (excluding abstract, references, tables/figures).

  • References: ≥ 50.

  • Tables/figures: Up to 12.

  • Structure:

    • Title: Indicate "Systematic review" and if it includes a meta-analysis.

    • Registration: PROSPERO (or OSF) registration mandatory; include ID.

    • Structured abstract (250 words): Background, Objective, Methods, Results, Conclusions, Registration.

    • Keywords: MeSH/DeCS.

    • Introduction: Justification and question (PICO/PEO/SPIDER).

    • Methods (PRISMA 2020): Reproducible search strategy (≥3 databases + grey literature, no language limits by default), management of duplicates, double-reviewer screening, PRISMA flowchart, inclusion/exclusion criteria, duplicate data extraction, risk of bias (Cochrane RoB 2, ROBINS-I, QUADAS-2, Newcastle-Ottawa/STROBE-based), GRADE for certainty of evidence. Synthesis: meta-analysis (random effects by default), heterogeneity (I², τ²), publication bias, pre-specified meta-regression/subgroups, sensitivity analysis.

    • Results: Characteristics of studies (table), risks of bias, forest plots with effects and 95% CI.

    • Discussion: Interpretation via GRADE, limitations of the evidence and of the review, implications.

    • Conclusions.

  • Supplementary material: Complete search strategy, extraction forms, GRADE tables, PRISMA checklists.

  • Notes: For qualitative reviews, use ENTREQ; for scoping reviews, PRISMA-ScR. Deposit extraction dataset and code in an open repository.

SCOPE REVISIONS

  • Scope: Mapping of literature, identification of key concepts, research gaps, and types of available evidence.

  • Length: Up to 4,500 words (excluding abstract, references, tables/figures).

  • References: ≥ 40.

  • Tables/figures: Up to 10.

  • Structure:

    • Title: Indicate "Scoping Review".

    • Registration: Recommended on OSF or another open repository (include ID).

    • Structured abstract (250 words): Background, Objective, Methods, Results, Conclusions, Registration.

    • Keywords: DeCS/MeSH.

    • Introduction: Justification, objectives, and question (e.g., PCC: Population, Concept, Context).

    • Methods (PRISMA-ScR): Broad and reproducible search strategy (≥3 main databases + grey literature), inclusion/exclusion criteria, double-reviewer screening and selection, duplicate data extraction, synthesis framework.

    • Results: PRISMA-ScR selection flowchart. Descriptive table of included studies. Narrative map or graphic of findings.

    • Discussion: Interpretative summary, identification of gaps and priority areas, limitations.

    • Conclusions: General synthesis and recommendations.

  • Supplementary material: Complete search strategy, extraction forms, PRISMA-ScR checklist.

  • Notes: Meta-analysis and risk of bias assessment are not performed by default, unless explicitly justified.

BIBLIOMETRIC REVIEWS

  • Scope: Quantitative and visual analysis of scientific production (trends, authors, institutions, countries, collaborations, emerging topics, co-occurrence networks).

  • Length: Up to 4,500 words (excluding abstract, references, tables/figures).

  • References: ≥ 40.

  • Tables/figures: Up to 12 (maps and network visualisations are favoured).

  • Structure:

    • Title: Indicate "Bibliometric review" or "Bibliometric analysis".

    • Structured abstract (250 words): Background, Objective, Methods, Results, Conclusions.

    • Keywords: DeCS/MeSH + terms related to bibliometrics/scientometrics.

    • Introduction: Justification, relevance of the field, research questions.

    • Methods: Databases (minimum 2), analysis period and search criteria, record cleaning procedure, software used and metrics utilised, statement of methodological transparency (PRISMA-ScR or PRISMA-S).

    • Results: Article selection flow (diagram). Descriptives (publications by year, authors, countries, institutions, journals). Networks and maps. Cluster analysis and emerging trends.

    • Discussion: Interpretation of findings, identification of leaders, thematic gaps and evolution, study limitations.

    • Conclusions: Synthesis of findings and projection of the field.

  • Supplementary material: Complete search equations, processed data files, analysis scripts.

  • Notes: It is recommended to deposit the final dataset and analysis code in an open repository.

NARRATIVE REVIEW

  • Scope: State of the art, critical synthesis of literature, conceptual or theoretical integration.

  • Length: Up to 5,000 words (excluding abstract, references, tables/figures).

  • References: ≥ 40.

  • Tables/figures: Up to 8.

  • Structure:

    • Title: Indicate "Narrative review".

    • Structured abstract (250 words): Background, Objective, Methods, Results, Conclusions.

    • Keywords: DeCS/MeSH.

    • Introduction: Justification, relevance, and delimitation of the topic.

    • Methods: Information sources (minimum 3 recognised databases), description of the selection process, reproducible search strategy, analysis framework, statement of quality framework (e.g., SANRA).

    • Results/Synthesis: Organised presentation of the literature by thematic axes, chronological or conceptual order; summary tables if applicable.

    • Discussion: Critical analysis of strengths and gaps, identification of controversies or inconsistencies, implications for research/practice/policy.

    • Conclusions: Main contributions and future agenda.

  • Notes: Methodological transparency is recommended; it is suggested to supplement with conceptual diagrams or thematic maps.

CLINICAL CASE REPORTS

  • Scope: Exceptional cases, rare phenomena, adverse reactions, challenging diagnoses, or clinical innovations with clear learning value.

  • Length: Up to 1,500 words (includes abstract, references, and tables/figures).

  • References: Up to 20.

  • Tables/figures: Up to 4.

  • Structure (CARE):

    • Title: Avoid identifiable information.

    • Brief abstract (200 words): Brief introduction, Case presentation, Key message.

    • Keywords: 3–5.

    • Introduction: Clinical relevance and objective.

    • Case presentation: Demographic data, history, findings, tests, differential diagnosis, intervention/treatment, outcome/follow-up.

    • Discussion: Teaching message, comparison with literature, limitations, applicability.

  • Explicit informed consent from the patient/representative is mandatory; attach the form if possible.

  • Ethics and privacy: Strict anonymisation of images/data; declare ethical approval if required by the committee.

  • Images: Mark arrows/indicators with description; delete identifying DICOM metadata.

CLINICAL GUIDELINES

  • Scope: Evidence-based practical recommendations for prevention, diagnosis, treatment, and follow-up.

  • Length: Up to 4,000 words (excluding references/tables/figures).

  • Methodology: GRADE (or equivalent) for rating certainty of evidence and strength of recommendations.

  • Structure:

    • Title and scope.

    • Summary of good practice: Key messages and decision algorithm(s).

    • Methods: Panel composition (conflict of interest statements), PICO questions, search strategy, evidence selection, certainty assessment (GRADE), consensus method, consideration of values and preferences, costs/resources, equity, acceptability, and feasibility.

    • Recommendations: Stated with strength (strong/conditional) and certainty (high-very low) + justification.

    • Implementation considerations and performance measures.

    • Update: Periodicity or "living guideline" criteria.

  • Appendices: Evidence tables (SoF), algorithms, GRADE/RIGHT checklists.

Copyright Notice

Submission Instruction
Authors are required to submit the copyright transfer form duly signed by all co-authors. The form can be downloaded from the following links:

AUTHORISATION FOR THE REPRODUCTION, USE, PUBLICATION, AND DISSEMINATION OF A LITERARY, ARTISTIC OR SCIENTIFIC WORK

I, [NAME OF AUTHOR(S)], of legal age, resident in the city of [CITY], identified with national ID card/passport No. [NUMBER], issued in [PLACE], being of sound mind and body, hereinafter referred to as THE AUTHOR, grant this authorisation for the reproduction, use, communication, and publication of the work under the following terms:

  1. Irrespective of the applicable legal provisions governing this agreement, THE AUTHOR hereby grants full and explicit authorisation to the Universidad del Norte to use the material entitled [TITLE OF THE WORK] in the journal.

  2. This authorisation is granted on an exclusive basis and includes reproduction rights by any means currently known or to be developed, public communication of the work in any form, distribution and commercialisation either directly or through third parties, for educational or commercial purposes. It also covers the transformation of the work, including changes of format, digitisation, translations, adaptations, or any other form of creating derivative works. This list is illustrative and does not preclude other editorial or economic uses that may arise.

  3. THE AUTHOR declares that the article is original, of their exclusive creation, and that there is no legal or contractual impediment to granting this authorisation. The AUTHOR also accepts responsibility for any claims arising from ownership disputes, plagiarism, or other related matters.

  4. This authorisation is granted free of charge.

  5. The moral rights of authorship of the article belong exclusively to THE AUTHOR. Accordingly, the Universidad del Norte undertakes to duly recognise and rigorously respect these rights.

THE AUTHOR

[Signature]
[Full name]
[Date]

Privacy Statement

The names and email addresses entered in this journal will be used exclusively for the purposes stated by the journal and will not be made available for any other purpose or to any other party.